Prancūzija - prancūzų - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

hameln pharma plus gmbh - sufentanil - solution - 50 microgrammes - composition pour 1 ml de solution injectable > sufentanil : 50 microgrammes . sous forme de : citrate de sufentanil - analgesiques generaux

Prancūzija - prancūzų - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

hameln pharma plus gmbh - sufentanil - solution - 5 microgrammes - composition pour 1 ml de solution injectable > sufentanil : 5 microgrammes . sous forme de : sufentanil (citrate de) - analgesiques generaux

Europos Sąjunga - prancūzų - EMA (European Medicines Agency)

taw pharma (ireland) limited - chlorhydrate de clopidogrel - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - agents antithrombotiques - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Šveicarija - prancūzų - Swissmedic (Swiss Agency for Therapeutic Products)

aspen pharma schweiz gmbh - chlorambucilum - comprimés pelliculés - chlorambucilum 2 mg, lactosum 67.65 mg, cellulosum microcristallinum, silica colloidalis anhydrica, acidum stearicum, hypromellosum, macrogolum 400, e 171, e 172 (flavum), e 172 (rubrum) pro compresso obducto. - cytostatique - synthetika

Šveicarija - prancūzų - Swissmedic (Swiss Agency for Therapeutic Products)

aspen pharma schweiz gmbh - tioguaninum - comprimés - tioguaninum 40 mg, lactosum monohydricum 150 mg, solani amylum, acaciae gummi, acidum stearicum, magnesii stearas, pro compresso. - leucémie aiguë - synthetika

Šveicarija - prancūzų - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - clomethiazolum - capsules - clomethiazolum 192 mg, excipiens pro capsula. - hypnoticum - synthetika

Šveicarija - prancūzų - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - clomethiazolum - mixtur - clomethiazolum 157.5 mg à clomethiazoli edisilas, sont, excipiens ad solution de 5 ml. - hypnoticum - synthetika

Šveicarija - prancūzų - Swissmedic (Swiss Agency for Therapeutic Products)

aspen pharma schweiz gmbh - labetaloli hydrochloridum - comprimés - labetaloli hydrochloridum 100 mg, color.: e 110, conserv.: e 211, excipiens pro compresso de la brume. - l'alpha et le bêta-bloquants - synthetika

Šveicarija - prancūzų - Swissmedic (Swiss Agency for Therapeutic Products)

aspen pharma schweiz gmbh - labetaloli hydrochloridum - comprimés - labetaloli hydrochloridum 200 mg, color.: e 110, conserv.: e 211, excipiens pro compresso de la brume. - l'alpha et le bêta-bloquants - synthetika

Šveicarija - prancūzų - Swissmedic (Swiss Agency for Therapeutic Products)

cps cito pharma services gmbh - phytomenadionum - injektionslösung / lösung zum einnehmen - phytomenadionum 10 mg, acidum glycocholicum, natrii hydroxidum, lecithinum, acidum hydrochloridum dilutum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 2.64 mg. - hypoprothrombinämie, antidote contre anticoagulantien du dicoumarol-type, la maladie de haemorrhagicus néonatal - synthetika